
    
      Patients with received in random order 75mg/day indometacin (Chronoindocid®), 10-20 mg/day
      amiloride and 50-150 mg /day eplerenone (Inspra ®). The three 6 weeks-periods of treatment
      will be followed by six weeks washout period. 3-6 weeks before the first period of treatment,
      a supplementation with potassium and magnesium will be orally given, and maintained at the
      same dose throughout the study and stoped 6 weeks after the end of the third period of
      treatment.
    
  